Hikma Pharmaceutical
HIK
Delayed London Stock Exchange - 11/17 05:35:14 pm
1041GBp
+1.96%
Prev.1021.0000
Open1020.0000
High1043.0000
Low999.0000
Volume1 138 619
Last news
Financials
Sales 2017 1 947 M
EBIT 2017 348 M
R. net 2017 173 M
Debt 2017 483 M
Rend. 2017 2,18%
P/E ratio 2017 18,43
P/E ratio 2018 16,77
EV / Sales 2017 1,95x
EV / Sales 2018 1,80x
Capitalization 3 305 M
Company
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products.It operates through the following segments: Branded, Injectables, Generics, and Others.The Branded segment offers selling of branded generics and in-licensed...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-03-14 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance1 0621 2331 496
Spread/Res.-2,0%-16%-30%
Spread/Supp.9,6%9,6%4,9%
Support950950992